141 related articles for article (PubMed ID: 37971615)
1. Letter to the Editor of Annals of Surgical Oncology Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA".
Chiu CC
Ann Surg Oncol; 2024 Apr; 31(4):2405-2407. PubMed ID: 37971615
[No Abstract] [Full Text] [Related]
2. Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA.
Raoof M; Whelan RL; Sullivan KM; Ruel C; Frankel PH; Cole SE; Tinsley R; Eng M; Fakih M; Chao J; Lim D; Woo Y; Paz IB; Lew M; Cristea M; Rodriguez-Rodriguez L; Fong Y; Thomas RM; Chang S; Deperalta D; Merchea A; Dellinger TH
Ann Surg Oncol; 2023 Nov; 30(12):7814-7824. PubMed ID: 37501051
[TBL] [Abstract][Full Text] [Related]
3. Reply to Letter to the Editor Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA".
Sullivan KM; Whelan RL; DePeralta D; Merchea A; Dellinger T; Raoof M
Ann Surg Oncol; 2024 Apr; 31(4):2408-2409. PubMed ID: 38245647
[No Abstract] [Full Text] [Related]
4. Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey.
Graversen M; Detlefsen S; Pfeiffer P; Lundell L; Mortensen MB
Clin Exp Metastasis; 2018 Mar; 35(3):103-108. PubMed ID: 29705882
[TBL] [Abstract][Full Text] [Related]
5. Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC).
Rovers KP; Wassenaar ECE; Lurvink RJ; Creemers GM; Burger JWA; Los M; Huysentruyt CJR; van Lijnschoten G; Nederend J; Lahaye MJ; Deenen MJ; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
Ann Surg Oncol; 2021 Sep; 28(9):5311-5326. PubMed ID: 33544279
[TBL] [Abstract][Full Text] [Related]
6. Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC).
Rovers KP; Lurvink RJ; Wassenaar EC; Kootstra TJ; Scholten HJ; Tajzai R; Deenen MJ; Nederend J; Lahaye MJ; Huysentruyt CJ; van 't Erve I; Fijneman RJ; Constantinides A; Kranenburg O; Los M; Thijs AM; Creemers GM; Burger JW; Wiezer MJ; Boerma D; Nienhuijs SW; de Hingh IH
BMJ Open; 2019 Jul; 9(7):e030408. PubMed ID: 31352425
[TBL] [Abstract][Full Text] [Related]
7. PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases.
Kim G; Tan HL; Sundar R; Lieske B; Chee CE; Ho J; Shabbir A; Babak MV; Ang WH; Goh BC; Yong WP; Wang L; So JBY
Clin Cancer Res; 2021 Apr; 27(7):1875-1881. PubMed ID: 33148667
[TBL] [Abstract][Full Text] [Related]
8. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.
Nowacki M; Alyami M; Villeneuve L; Mercier F; Hubner M; Willaert W; Ceelen W; Reymond M; Pezet D; Arvieux C; Khomyakov V; Lay L; Gianni S; Zegarski W; Bakrin N; Glehen O
Eur J Surg Oncol; 2018 Jul; 44(7):991-996. PubMed ID: 29526367
[TBL] [Abstract][Full Text] [Related]
9. A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial.
Glockzin G; Rochon J; Arnold D; Lang SA; Klebl F; Zeman F; Koller M; Schlitt HJ; Piso P
BMC Cancer; 2013 Feb; 13():67. PubMed ID: 23391248
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC).
Lurvink RJ; Rovers KP; Wassenaar ECE; Bakkers C; Burger JWA; Creemers GM; Los M; Mols F; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
Surg Endosc; 2022 Jun; 36(6):4486-4498. PubMed ID: 34757489
[TBL] [Abstract][Full Text] [Related]
11. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis.
Demtröder C; Solass W; Zieren J; Strumberg D; Giger-Pabst U; Reymond MA
Colorectal Dis; 2016 Apr; 18(4):364-71. PubMed ID: 26400556
[TBL] [Abstract][Full Text] [Related]
12. Morbidity associated with the use of oxaliplatin versus mitomycin C in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal or appendiceal origin: a multi-institutional comparative study.
Benzaquen E; Wang Y; Wiseman S; Rosenfeld V; Sideris L; Dubé P; Pelletier JS; Vanounou T
Can J Surg; 2021 Mar; 64(2):E111-E118. PubMed ID: 33651573
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study.
Sgarbura O; Hübner M; Alyami M; Eveno C; Gagnière J; Pache B; Pocard M; Bakrin N; Quénet F
Eur J Surg Oncol; 2019 Dec; 45(12):2386-2391. PubMed ID: 31092362
[TBL] [Abstract][Full Text] [Related]
14. Multicenter dose-escalation Phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and colorectal peritoneal metastases: rationale and design.
Raoof M; Sullivan KM; Frankel PH; Fakih M; Synold TW; Lim D; Woo Y; Paz IB; Fong Y; Thomas RM; Chang S; Eng M; Tinsley R; Whelan RL; Deperalta D; Reymond MA; Jones J; Merchea A; Dellinger TH
Pleura Peritoneum; 2022 Dec; 7(4):169-177. PubMed ID: 36560966
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy With or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study.
Taibi A; Sgarbura O; Hübner M; Bardet SM; Alyami M; Bakrin N; Durand Fontanier S; Eveno C; Gagniere J; Pache B; Pocard M; Quenet F; Teixeira Farinha H; Thibaudeau E; Dumont F; Glehen O
Ann Surg Oncol; 2022 Aug; 29(8):5243-5251. PubMed ID: 35318519
[TBL] [Abstract][Full Text] [Related]
16. First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II).
Lurvink RJ; Rauwerdink P; Rovers KP; Wassenaar ECE; Deenen MJ; Nederend J; Huysentruyt CJR; van 't Erve I; Fijneman RJA; van der Hoeven EJRJ; Seldenrijk CA; Constantinides A; Kranenburg O; Los M; Herbschleb KH; Thijs AMJ; Creemers GM; Burger JWA; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
BMJ Open; 2021 Mar; 11(3):e044811. PubMed ID: 33785492
[TBL] [Abstract][Full Text] [Related]
17. PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial.
Raoof M; Malhotra G; Kohut A; O'Leary M; Frankel P; Tran T; Fakih M; Chao J; Lim D; Woo Y; Paz IB; Lew M; Cristea MC; Rodriguez-Rodriguez L; Fong Y; Blakely A; Whelan R; Reymond MA; Merchea A; Dellinger TH
Ann Surg Oncol; 2022 Jan; 29(1):175-185. PubMed ID: 34387765
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of perioperative intraperitoneal chemotherapy regimen in appendiceal and colorectal peritoneal carcinomatosis.
Chua TC; Liauw W; Zhao J; Morris DL
Int J Clin Oncol; 2013 Jun; 18(3):439-46. PubMed ID: 22415741
[TBL] [Abstract][Full Text] [Related]
19. RE: Phase I dose escalation study of oxaliplatin delivered via a laparoscopic approach using pressurized intraperitoneal aerosol chemotherapy (PIPAC) for advanced peritoneal metastases of gastrointestinal tract cancers: PIPAC-oxaliplatin for peritoneal metastases of gastrointestinal cancers.
Rovers KP; Lurvink RJ; Deenen MJ; de Hingh IHJT
Eur J Cancer; 2021 Apr; 147():182-184. PubMed ID: 33640212
[No Abstract] [Full Text] [Related]
20. Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study.
Graversen M; Detlefsen S; Ainsworth AP; Fristrup CW; Knudsen AO; Pfeiffer P; Tarpgaard LS; Mortensen MB
Ann Surg Oncol; 2023 May; 30(5):2634-2644. PubMed ID: 36602663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]